Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- NK-Cell Leukemia
- NK Cell Lymphoma
- Peripheral T Cell Lymphoma
- Type
- Interventional
- Phase
- Early Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Cohort 1 and 2 will be based on initial diagnosis.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 1 years and 31 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03719105
- Collaborators
- University of Alabama at Birmingham
- Investigators
- Study Director: Mitchell Cairo, MD New York Medical College
Get Well Soon